ArticleClinical epigenetics2023

A study of using epigenetic modulators to enhance response to pembrolizumab (MK-3475) in microsatellite stable advanced colorectal cancer.

Marina Baretti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.